None listed
Conditions
Interventions
5 years who had a diagnosis of asthma (include AD,
AR) by GINA guideline 2018
,Children aged 2-
5 years recurrent wheezing ≥ 2 episodes confirmed by physician
,Healthy children aged 2-
5 years
no underlying disease
Diagnostic,Diagnostic,Diagnostic
asthma group,Viral induced wheezing group,control group
Sponsors
research fund and deta analysis unit, Faculty of Medicine Ramathibodi Hospital
research fund and deta analysis unit,
Faculty of Medicine Ramathibodi Hospital,research fund and deta analysis unit,
Faculty of Medicine Ramathibodi Hospital
Eligibility
Sex/Gender
All
Age
2 Years to 6 Years
Inclusion criteria
Inclusion criteria: asthma group : Children aged 2-5 years who had a diagnosis of asthma (include AD,AR) by GINA guideline 2018 Viral induced wheezing group :Children aged 2-5 years recurrent wheezing ≥ 2 episodes confirmed by physician control group :Healthy children aged 2-5 years no underlying disease
Exclusion criteria
Exclusion criteria: asthma group :Post respiratory tract infection in 4 week Coexisting disease : Malignancy Active autoimmune disease HIV infection Cardiovascular diseases Immunodeficiency Chronic lung disease -Inhaled corticosteroid use in 4 week Viral induced wheezing group :Post respiratory tract infection in 4 week Coexisting disease : Malignancy Active autoimmune disease HIV infection Cardiovascular diseases Immunodeficiency Chronic lung disease -Inhaled corticosteroid use in 4 week -allergen sensitization control group :Post respiratory tract infection in 4 week history allergen sensitization and atopy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum periostin 1 year regression analysis | — |
Secondary
| Measure | Time frame |
|---|---|
| eosinophil cationic protein 1 year ANOVA | — |
Countries
Thailand
Contacts
Public ContactPailin Yooma
Faculty of Medicine Ramathibodi Hospital,Mahidol Universit
Outcome results
None listed